A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
Clinical trial NCT07089706 · COMPLETED
Trial details
- NCT number
- NCT07089706
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-21
- Primary completion
- 2026-06-16
- Enrollment
- 832
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.